Reviewing P3 Health Partners (PIII) & Its Peers

P3 Health Partners (NASDAQ:PIII) is one of 34 public companies in the “Health services” industry, but how does it contrast to its rivals? We will compare P3 Health Partners to related businesses based on the strength of its valuation, dividends, risk, analyst recommendations, institutional ownership, earnings and profitability.

Valuation & Earnings

This table compares P3 Health Partners and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
P3 Health Partners	$1.05 billion	-$270.13 million	0.00
P3 Health Partners Competitors	$1.51 billion	-$94.28 million	17.34

P3 Health Partners’ rivals have higher revenue and earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

P3 Health Partners has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. Comparatively, P3 Health Partners’ rivals have a beta of 1.37, indicating that their average share price is 37% more volatile than the S&P 500.

Institutional & Insider Ownership

23.6% of P3 Health Partners shares are owned by institutional investors. Comparatively, 44.9% of shares of all “Health services” companies are owned by institutional investors. 17.1% of P3 Health Partners shares are owned by insiders. Comparatively, 22.7% of shares of all “Health services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares P3 Health Partners and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-10.92%	-2,471.27%	33.63%
P3 Health Partners Competitors	-136.76%	-192.17%	-18.55%

Analyst Recommendations

This is a summary of recent ratings and target prices for P3 Health Partners and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	0	1	1	0	2.50
P3 Health Partners Competitors	10	164	317	0	2.63

P3 Health Partners currently has a consensus price target of $5.00, suggesting a potential upside of 135.85%. As a group, “Health services” companies have a potential upside of 107.60%. Given P3 Health Partners’ higher possible upside, analysts plainly believe P3 Health Partners is more favorable than its rivals.

Summary

P3 Health Partners rivals beat P3 Health Partners on 9 of the 12 factors compared.

P3 Health Partners Company Profile

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.